share_log

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(13.4%),O. Andreas Halvorsen(13.4%), etc.

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(13.4%),O. Andreas Halvorsen(13.4%), etc.

BridgeBio Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-Viking Global Investors LP(13.4%),O. Andreas Halvorsen(13.4%)等
美股SEC公告 ·  08/20 20:43
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息